On May 10, 2012, a Food and Drug Administration advisory panel recommended for the first time the use of an HIV medication
to prevent healthy people from becoming infected with the virus that causes AIDS. Rodney Wright, M.D., assistant professor of obstetrics
& gynecology and women's health at Albert Einstein College of Medicine of Yeshiva University and director of HIV programs in the
department of obstetrics and gynecology at Montefiore Medical Center, discusses this new use of Truvada -- both its benefits and
potential hazards. Learn more about the FDA vote: http://www.nytimes.com/2012/05/11/health/policy/fda-panel-weighs-preventive-u...